ArticleCancers2025

Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy.

Teiji Kuzuya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.